DuPont Completes Acquisition of Donatelle Plastics Incorporated

Rhea-AI Summary

DuPont (NYSE: DD) has completed the acquisition of Donatelle Plastics, a leading medical device company specializing in medical components and devices. The acquisition brings complementary advanced technologies and capabilities to DuPont's Electronics & Industrial segment, including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building.

Donatelle, with over 400 employees, will become part of the Industrial Solutions line of business. The company has a strong growth profile with offerings aligned to attractive therapeutic areas such as electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities. This acquisition is expected to enhance DuPont's healthcare offerings and expand its capabilities in the medical device sector.

Positive

• Acquisition of Donatelle Plastics brings advanced manufacturing capabilities to DuPont
• Donatelle has a strong growth profile in attractive therapeutic areas
• Addition of over 400 skilled employees to DuPont's workforce
• Expansion of DuPont's healthcare offerings and customer relationships

Negative

• None.

WILMINGTON, Del., July 29, 2024 /PRNewswire/ -- DuPont (NYSE: DD) today announced that it has completed the previously announced acquisition of Donatelle Plastics ("Donatelle"), a leading medical device company specializing in medical components and devices.

"I'm pleased to welcome the talented Donatelle colleagues to DuPont," said Jon Kemp, President, DuPont Electronics & Industrial (E&I). "We're excited to add Donatelle's best-in-class advanced injection molding manufacturing capabilities, and decades-long customer relationships with large medical device equipment manufacturers to E&I's healthcare offerings."

With a workforce of more than 400 employees, Donatelle becomes part of the Industrial Solutions line of business within the Electronics & Industrial segment. The acquisition of Donatelle brings complementary advanced technologies and capabilities including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building. Donatelle has a strong growth profile with offerings aligned to attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.  

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, healthcare and worker safety. More information about the company, its businesses and solutions can be found at www.dupont.com. Investors can access information included on the Investor Relations section of the website at investors.dupont.com.

DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, ^SM or ^® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dupont-completes-acquisition-of-donatelle-plastics-incorporated-302208211.html

SOURCE DuPont

FAQ

What company did DuPont (DD) acquire on July 29, 2024?

DuPont (DD) completed the acquisition of Donatelle Plastics, a leading medical device company specializing in medical components and devices, on July 29, 2024.

What capabilities does the Donatelle acquisition bring to DuPont (DD)?

The Donatelle acquisition brings complementary advanced technologies and capabilities to DuPont, including medical device injection molding, liquid silicone rubber processing, precision machining, device assembly, and tool building.

How many employees does Donatelle bring to DuPont (DD) through this acquisition?

Donatelle brings a workforce of more than 400 employees to DuPont through this acquisition.

What therapeutic areas does Donatelle's product offerings align with?

Donatelle's offerings align with attractive therapeutic areas including electrophysiology, drug delivery, diagnostics, cardiac rhythm management, neurostimulation, and orthopedic extremities.